首页> 外文期刊>European journal of pain : >Long-term reliable change of pain scores in individual myogenous TMD patients.
【24h】

Long-term reliable change of pain scores in individual myogenous TMD patients.

机译:个别肌源性TMD患者的疼痛评分长期可靠变化。

获取原文
获取原文并翻译 | 示例
       

摘要

A within-patient change in pain score after treatment is statistically 'reliable' when it exceeds the smallest detectable difference (SDD). The aims of the present study were to: (i) determine SDDs for VAS-scores of pain intensity, for sufficiently long test-retest intervals to include most biological fluctuations, (ii) examine whether SDD is invariant to baseline score, and (iii) discuss the value of reliable change (RC) for detecting clinically important difference (CID) or as a possible indicator of successful treatment. SDDs were determined using duplicate data from 118 patients with myogenous Temporomandibular disorders: (1) VAS-scores of pain intensity from the masticatory system in a pre-treatment diary, and (2) VAS-scores of pain intensity from the hand (cold-pressor test). RC was determined in VAS-scores from a pre- and post-treatment questionnaire. The long-term SDD was 49mm. A regression analysis on duplicate VAS-scores showed that SDD was largely invariant to the baseline level. Because RC (change>SDD) exceeded CID, it might serve as an indicator of successful treatment. However, only 17% of the patients showed RC after treatment, mainly because the baseline was smaller than SDD in 67% of the patients thus making detection of any treatment effect impossible. For patients with possible detection (33%), the frequency of RC was 51%. If the detection threshold would be avoided by provoking pain in patients with a low baseline, a long-term RC in VAS-scores might occur in about half of all myogenous TMD patients and might then serve as an indicator of cases of treatment success.
机译:当患者内的疼痛评分变化超过最小可检测差异(SDD)时,其在统计学上是“可靠的”。本研究的目的是:(i)确定疼痛强度的VAS评分的SDD,在足够长的测试-再测间隔内包括大多数生物学波动,(ii)检查SDD是否与基线评分无关,并且(iii )讨论了可靠变化(RC)在检测临床上的重要差异(CID)或作为成功治疗的可能指标方面的价值。使用来自118例患有肌源性颞下颌关节疾病的患者的重复数据确定SDD:(1)治疗前日记中咀嚼系统的疼痛强度的VAS评分,以及(2)手部疼痛强度的VAS评分(冷加压测试)。根据治疗前和治疗后问卷在VAS评分中确定RC。长期SDD为49mm。对重复的VAS分数进行的回归分析表明,SDD在基线水平上基本不变。因为RC(change> SDD)超过了CID,所以它可以作为治疗成功的指标。但是,只有17%的患者在治疗后出现RC,主要是因为基线低于67%的患者的SDD,因此无法检测到任何治疗效果。对于可能检出的患者(33%),RC的发生率为51%。如果可以通过在基线较低的患者中引起疼痛来避免检测阈值,则在所有成肌TMD患者中大约一半会发生VAS评分的长期RC,然后可以作为治疗成功案例的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号